Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Dapagliflozin uk generic launch?Entresto regulatory challenges?Patent protection for bimzelx hs indication?Entresto generic market cap?Entresto patent litigations?
See the DrugPatentWatch profile for Nivolumab
Nivolumab is marketed under the brand name Opdivo and is made by Bristol Myers Squibb (BMS). [1]
In most markets, Opdivo (nivolumab) is the branded product supplied by Bristol Myers Squibb. Biosimilar manufacturers would only be relevant if an approved biosimilar version is available in a given country.
For company and patent-tracking information related to nivolumab, DrugPatentWatch.com is one place to look. [1]
1
Other Questions About Nivolumab :